These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 25757851

  • 1. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ, Olszewski AJ, Hunter ZR, Kanan S, Meid K, Treon SP.
    Cancer; 2015 Jul 01; 121(13):2230-6. PubMed ID: 25757851
    [Abstract] [Full Text] [Related]

  • 2. Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.
    Morra E, Varettoni M, Tedeschi A, Arcaini L, Ricci F, Pascutto C, Rattotti S, Vismara E, Paris L, Cazzola M.
    Clin Lymphoma Myeloma Leuk; 2013 Dec 01; 13(6):700-3. PubMed ID: 24070824
    [Abstract] [Full Text] [Related]

  • 3. Incidence and Risk of Secondary Malignancy in Patients with Waldenström Macroglobulinemia: A Population-Based Analysis.
    Rehman MEU, Hameed M, Shah Z, Ashruf OS, Ali R, Faraz F, Basit J, Khan I, Fazal F, Iftikhar A, Nashwan AJ, Faisal MS, Anwer F.
    Clin Hematol Int; 2024 Dec 01; 6(1):3-12. PubMed ID: 38817692
    [Abstract] [Full Text] [Related]

  • 4. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP.
    Am J Hematol; 2015 Aug 01; 90(8):696-701. PubMed ID: 25963924
    [Abstract] [Full Text] [Related]

  • 5. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 01; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 6. Risk of second cancers in Waldenström macroglobulinemia.
    Varettoni M, Tedeschi A, Arcaini L, Pascutto C, Vismara E, Orlandi E, Ricci F, Corso A, Greco A, Mangiacavalli S, Lazzarino M, Morra E.
    Ann Oncol; 2012 Feb 01; 23(2):411-5. PubMed ID: 21525403
    [Abstract] [Full Text] [Related]

  • 7. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 8. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
    Castillo JJ, Gertz MA.
    Leuk Lymphoma; 2017 Apr 07; 58(4):773-780. PubMed ID: 27546465
    [Abstract] [Full Text] [Related]

  • 9. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
    Hanzis C, Ojha RP, Hunter Z, Manning R, Lewicki M, Brodsky P, Ioakimidis L, Tripsas C, Patterson CJ, Sheehy P, Treon SP.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 07; 11(1):88-92. PubMed ID: 21454200
    [Abstract] [Full Text] [Related]

  • 10. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working GroupAIRTUM Working Group: tumori.infantili@registri-tumori.it..
    Epidemiol Prev; 2013 Feb 07; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [Abstract] [Full Text] [Related]

  • 11. Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP.
    Br J Haematol; 2015 Apr 07; 169(1):81-9. PubMed ID: 25521528
    [Abstract] [Full Text] [Related]

  • 12. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE.
    Cancer; 2016 Jan 01; 122(1):116-23. PubMed ID: 26441212
    [Abstract] [Full Text] [Related]

  • 13. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ, Keegan TH, Press DJ, Yang J, Pincus LB, Kim YH, Chang ET.
    JAMA Dermatol; 2014 Jul 01; 150(7):709-15. PubMed ID: 24718769
    [Abstract] [Full Text] [Related]

  • 14. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R, Bazzeh F, Faqih N, Sultan I.
    Cancer; 2010 Sep 15; 116(18):4385-94. PubMed ID: 20549819
    [Abstract] [Full Text] [Related]

  • 15. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O.
    Clin Genitourin Cancer; 2017 Oct 15; 15(5):e747-e754. PubMed ID: 28314541
    [Abstract] [Full Text] [Related]

  • 16. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study.
    Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian R, Kwak L, Rustveld L, Du XL, Wang M.
    Cancer; 2012 Aug 01; 118(15):3793-800. PubMed ID: 22139816
    [Abstract] [Full Text] [Related]

  • 17. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S, Bhatt VR, Verma V, Pathak R, Bociek RG, Vose JM, Armitage JO.
    Clin Lymphoma Myeloma Leuk; 2017 Sep 01; 17(9):569-574. PubMed ID: 28709798
    [Abstract] [Full Text] [Related]

  • 18. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK, Khanal A.
    Anticancer Res; 2015 Jun 01; 35(6):3437-40. PubMed ID: 26026107
    [Abstract] [Full Text] [Related]

  • 19. Increased incidence of a second lymphoproliferative malignancy in patients with multiple myeloma--a SEER based study.
    Chakraborty S, Hauke RJ, Bonthu N, Tarantolo SR.
    Anticancer Res; 2012 Oct 01; 32(10):4507-15. PubMed ID: 23060579
    [Abstract] [Full Text] [Related]

  • 20. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X, Soumerai J, Roccaro A, Hatjiharissi E, Hunter ZR, Manning R, Ciccarelli BT, Sacco A, Ioakimidis L, Adamia S, Moreau AS, Patterson CJ, Ghobrial IM, Treon SP.
    J Clin Oncol; 2009 Jan 10; 27(2):250-5. PubMed ID: 19064987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.